Debiopharm commences pivotal glioblastoma therapy study
The therapy is a brain-penetrant used in various combinations in patients with progressive glioblastoma
Read More
Tag: Debiopharm
Debiopharm reveals phase 1/2 GaLuCi research results
The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate
Read More
Merck, Pfizer link with Debiopharm to test immunotherapy combo
Merck KGaA and Pfizer have entered into a collaboration with Debiopharm International to evaluate the potential of combining their drugs to treat lung cancer.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
